Galleon, Marilyn .

HRN: 24-70-16  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2024
CEFUROXIME 1.5GM (VIAL)
03/23/2024
03/24/2024
IV
1.5gm
Q8
Sp Cs
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes